Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Design Therapeutics (DSGN) Income from Continuing Operations: 2020

Historic Income from Continuing Operations for Design Therapeutics (DSGN) over the last 1 years, with Dec 2020 value amounting to -$8.3 million.

  • Design Therapeutics' Income from Continuing Operations was N/A to -$3.9 million in Q4 2020 from the same period last year, while for Dec 2020 it was -$8.3 million, marking a year-over-year change of. This contributed to the annual value of -$8.3 million for FY2020, which is N/A change from last year.
  • According to the latest figures from FY2020, Design Therapeutics' Income from Continuing Operations is -$8.3 million.
  • Design Therapeutics' Income from Continuing Operations' 5-year high stood at -$8.3 million during FY2020, with a 5-year trough of -$8.3 million in FY2020.
  • Moreover, its 1-year median value for Income from Continuing Operations was -$8.3 million (2020), whereas its average is -$8.3 million.